Saudi Arabia vs Uruguay: The number of people with susceptibility test result for rifampicin
Saudi Arabia
591
in 2021
Uruguay
510
in 2021
Saudi Arabia rank
77th
Uruguay rank
78th
The number of people with susceptibility test result for rifampicin over time
- Saudi Arabia
- Uruguay
How they compare
Saudi Arabia currently reports 591 against 510 in Uruguay, a difference of 81.
That makes Saudi Arabia's figure about 1.2 times Uruguay's.
Across all 5 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 77th and Uruguay ranks 78th of 155 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,131 | 508 | 623 | Saudi Arabia |
| 2020s | 590.5 | 493 | 97.5 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Saudi Arabia or Uruguay?
- Saudi Arabia, at 591 against 510 in Uruguay as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Saudi Arabia and Uruguay?
- 81, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Uruguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Saudi Arabia and Uruguay rank globally for the number of people with susceptibility test result for rifampicin?
- Saudi Arabia ranks 77th and Uruguay ranks 78th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.